A publication referencing TB-500 was released on April 7, 2026. The article, titled "Therapeutic peptides in gerontology: mechanisms and applications for healthy aging," appeared in the journal Frontiers in Aging.
TB-500 remains classified as an unapproved research compound. This entry reflects the appearance of a new publication discussing therapeutic peptides in the context of gerontology, as indexed under PubMed ID 42021992.
No findings, results, or conclusions from the publication are detailed here beyond its title, journal, and publication date. Readers interested in the underlying content are encouraged to consult the original source directly for full details.
For additional background on TB-500, including its regulatory status and general context, readers can consult the compound overview.